Research helps explain how B cell metabolism is controlledJanuary 23, 2017
La Jolla, Calif., January 23, 2016 (embargoed until 11:00 A.M. EST) -- B cells, the lymphocytes best known for making antibodies, live a complex life. They start developing in the bone marrow and then move through the spleen, lymph nodes and blood, taking on tasks that range from recognizing foreign substances to replication, quiescence, and generating a lasting memory of pathogens. But little is known about how B cell metabolism adapts to each of these environments, insights that may improve our understanding of B cell diseases, such as non-Hodgkin's lymphoma.
"Our research shows that the protein GSK3 plays a crucial role in helping B cells meet the energy needs of their distinct states," says Robert Rickert, Ph.D., director of the Tumor Microenvironment and Cancer Immunology Program at Sanford Burnham Prebys Medical Discovery Institute (SBP). "It acts as a metabolic sensor, or checkpoint, that promotes the survival of circulating B cells while limiting growth and proliferation of B cells in germinal centers. The findings are particularly relevant for certain B cell pathologies, including lymphoma subtypes, where there is an increased demand for energy to support the hyperproliferation of cells in a microenvironment that may be limited in nutrients."
B cells have different metabolic needs depending on their environment. In the blood, circulating B cells are quiescent, consuming little energy. In germinal centers--the sites within lymph nodes where mature B cells cluster--B cells proliferate and undergo hypermutation of their antibody genes to generate high-affinity antibodies. These processes require enormous amounts of energy, so these B cells consume lots of sugars, fatty acids and amino acids.
The new study, published today in Nature Immunology, found that GSK3 adjusts metabolism to match each of these needs. In circulating B cells, GSK3 limits overall metabolic activity, while in proliferating B cells in germinal centers, GSK3 slows glycolysis and production of mitochondria.
GSK3 function is essential for B cell survival in germinal centers. To understand why, Rickert's team looked at how B cells in these regions generate energy, and found that because these B cells are so metabolically active, they consume nearly all available glucose. That switches on a secondary, less efficient but non-oxygen-dependent means of generating energy called glycolysis. High glycolytic activity leads to accumulation of toxic reactive oxygen species (ROS), as does rapid manufacture of mitochondria, which tend to leak the same chemicals. Thus, by restraining metabolism in specific ways, GSK3 prevents ROS-induced cell death.
"Our results were really surprising," Rickert commented. "Until now, we would have thought that slowing metabolism would only be important for preventing B cells from becoming cancerous--which it indeed may be. These studies provide insight into the dynamic nature of B cell metabolism that literally 'fuels' differentiation in the germinal center to produce an effective antibody response"
"It's not yet clear whether or how GSK3 might be a target for future therapies for B cell-related diseases, but this research opens a lot of doors for further studies," Rickert said. "To start with, we plan to investigate how GSK3 is regulated in lymphoma and how that relates to changes in metabolism. That research could lead to new approaches to treating lymphoma."
Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit medical research organization that conducts world-class, collaborative, biological research and translates its discoveries for the benefit of patients. SBP focuses its research on cancer, immunity, neurodegeneration, metabolic disorders and rare children's diseases. The Institute invests in talent, technology and partnerships to accelerate the translation of laboratory discoveries that will have the greatest impact on patients. Recognized for its world-class NCI-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, SBP employs about 1,100 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.
Sanford-Burnham Prebys Medical Discovery Institute
Related Lymphoma Articles:
EPFL scientists have discovered an important gene whose loss lies behind follicular lymphoma, an incurable cancer.
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
Many people survive well beyond 10 years following diagnosis of follicular lymphoma.
In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy.
The SingHealth Duke-NUS Academic Medical Centre announced today that a S$2.5 million Tanoto Foundation Professorship in Medical Oncology has been conferred to Assoc Prof Lim Soon Thye, Head and Senior Consultant of the Division of Medical Oncology at the National Cancer Centre Singapore; and Assistant Dean at Duke-NUS Medical School.
Protein chemists at Johns Hopkins report they are closer to explaining why certain blood cancers are able to crack a molecular security system and run rampant.
The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology.
Natural killer cells of the immune system can fend off malignant lymphoma cells and thus are considered a promising therapeutic approach.
Non-Hodgkin lymphoma, a potentially devastating cancer of the blood and immune system, can range from relatively easy to treat to very aggressive.
Hodgkin's lymphoma -- cancer of the lymph nodes -- arises in more than 150 children and adolescents in Germany each year.
Related Lymphoma Reading:
Living with Lymphoma: A Patient's Guide (Johns Hopkins Press Health Books (Paperback))
by Elizabeth M. Adler PhD (Author), Michael R. Bishop MD (Introduction), W. Jeffrey Baker MD (Introduction)
When neurobiologist Elizabeth M. Adler was diagnosed with non-Hodgkin lymphoma almost twenty years ago, she learned everything she could about the disease, both to cope with the emotional stress of her diagnosis and to make the best possible decisions for her treatment. In Living with Lymphoma, she combines her scientific expertise and personal knowledge with a desire to help other people who have lymphoma manage this complex and often baffling disease.
With the availability of more effective treatment regimens, many people with lymphoma are living longer; in fact, there are... View Details
100 Questions & Answers About Lymphoma
by Peter Holman (Author), Gregory Bociek (Author), Jodi Garrett (Author)
Written by oncology experts with over 20 years of experience, 100 Questions and Answers About Lymphoma, Third Edition provides authoritative answers to your questions on lymphoma. Featuring the information you need in one concise, easy-to-read volume, 100 Questions and Answers About Lymphoma, Third Edition is an invaluable resource for newly diagnosed patients, survivors, friends or relatives of either. This newly updated text features information on the latest, cutting-edge treatments and medication, Hodgkin's and Non-Hodgkin's lymphoma, natural killer cells, T-cell lymphoma, autoimmune... View Details
by James O. Armitage MD (Editor), Peter M. Mauch MD (Editor), Nancy Lee Harris MD (Editor), Bertrand Coiffier MD (Editor), Riccardo Dalla-Favera MD (Editor)
Thoroughly updated for its Second Edition, Non-Hodgkin Lymphomas is the definitive textbook on the biology, diagnosis, staging, and treatment of all forms of non-Hodgkin lymphomas. With backgrounds in medical and radiation oncology, molecular biology, and pathology, the editors and contributors provide an international, multidisciplinary approach to the topic.
This edition is the first text using the new World Health Organization classification of non-Hodgkin lymphomas. The book offers complete coverage of the most current techniques for diagnosis, staging, and treatment, the... View Details
Handbook of Lymphoma
by Anas Younes (Editor)
The Handbook of Lymphoma is an in-depth and comprehensive guide to the diagnosis, staging, treatment, and management of patients with the disease. The Handbook aims to provide healthcare professionals with an informative and up-to-date guide to the latest developments in the treatment of patients with both Hodgkin and non-Hodgkin lymphoma. Lymphoma is a cancer of the lymphatic system and, as with other cancers, is a disease of the body's cells. Usually, cells divide in the body in an orderly and controlled manner, however when this process gets out of control and the cells carry on dividing... View Details
Lymphoma: Pathology, Diagnosis, and Treatment (Cambridge Medicine (Hardcover))
by Dr Robert Marcus (Editor), John W. Sweetenham (Editor), Michael E. Williams (Editor)
Major advances have occurred in the diagnosis and treatment of lymphoma in recent years. Our understanding of the molecular biology and genetics of the disease has increased exponentially, and significant imaging developments have resulted in earlier and more accurate diagnosis. The new edition of this landmark text places these advances in the context of daily clinical practice. Each chapter has been updated to reflect recent developments, including new treatment agents such as immunomodulatory drugs and the next generation of antibodies, and the increasing prognostic role of PET scanning.... View Details
Lymphomas and Leukemias: Cancer: Principles & Practice of Oncology, 10th edition
by Vincent T. DeVita Jr. MD (Author), Theodore S. Lawrence MD PhD (Author), Steven A. Rosenberg MD PhD (Author)
Selected from the world’s leading comprehensive cancer textbook, this tightly focused resource provides you with the practical, cutting-edge information you need to provide the best cancer care to each patient. Lymphomas and Leukemias: Cancer: Principles & Practice of Oncology, 10th Edition, offers a complete and balanced view of this rapidly changing field, meeting the needs of oncology/hematology practitioners, fellows, and others who need an in-depth understanding of leukemias and lymphomas. The print reference gives you the solid, dependable guidance you have come to expect from... View Details
Skin Lymphoma: The Illustrated Guide
by Lorenzo Cerroni (Author)
Skin Lymphoma: The Illustrated Guide presents a templated, easy to follow approach to the diagnosis of this challenging condition. Hundreds of outstanding full colour images, carefully chosen for their clinical relevance, are complemented by a standard chapter format which covers clinical features, histopathology, diagnosis, treatment and prognosis. Teaching cases throughout the text highlight examples of particular interest for trainees, and summary boxes highlight key points for quick review.
This new fourth edition has been fully updated in line with new WHO... View Details
Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas, 2e
by L. Jeffrey Medeiros MD (Author), Roberto N. Miranda MD (Author)
Part of the highly regarded Diagnostic Pathology series, this updated volume is a visually stunning, easy-to-use reference covering all aspects of benign and malignant lesions of lymph node, spleen, and extranodal lymphomas. Outstanding images make this an invaluable diagnostic aid for every practicing pathologist, resident, or fellow. This second edition incorporates the most recent clinical, pathological, histological, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice.Unsurpassed visual... View Details
NCCN Guidelines for Patients®: Follicular Lymphoma, 2017
by National Comprehensive Cancer Network® (NCCN®) (Author)
[OFFICIAL CURRENT VERSION] From the medical leaders of 27 leading cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to follicular lymphoma. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1 -... View Details
Cutaneous Lymphoma: Diagnosis and Treatment
by John C Hall (Author), Brian J Hall (Author)
Drs. John C. Hall and Brian J. Hall have assembled world leaders on this ever-changing topic of Cutaneous Lymphoma, to explore advances in research. The text first discusses the new classifications of cutaneous lymphoma. Epidemiology is then reviewed. A general approach to the patient suspected of having a cutaneous lymphoma is outlined. Diagnosis, histopathology, molecular genetics, and treatment of each subgroup is discussed. Precursors and mimics, which make this such a fascinating group of diseases, are reviewed. Systemic considerations of this primarily cutaneous disease are also... View Details